- Reports Third-Quarter Diluted EPS of $0.97 on a GAAP Basis; Adjusted Diluted EPS of $1.21, Reflecting Growth of 7.1 Percent Over Third-Quarter 2015 - Delivers Third-Quarter Net Revenues of $6.43 Billion on a GAAP Basis; Adjusted Net Revenues Grew 8.0 Percent on an Operational Basis - Revenue

NORTH CHICAGO, Ill. , Oct. 10, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2016 financial results on Friday, October 28, 2016 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).

NORTH CHICAGO, Ill. , Sept. 9, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.57 per share.  The cash dividend is payable Nov. 15, 2016 to stockholders of record at the close of business on Oct. 14, 2016 .

NORTH CHICAGO, Ill. , Aug. 30, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 14, 2016 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at 10:40

- Reports Second-Quarter Diluted EPS of $0.98 on GAAP Basis; Adjusted Diluted EPS of $1.26, Reflecting Growth of 16.7 Percent Over Second-Quarter 2015 - Delivers Second-Quarter Net Revenues of $6.45 Billion; $6.43 Billion on Adjusted Basis, Reflecting an 18.0 Percent Increase Operationally -

NORTH CHICAGO, Ill. , July 1, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its second-quarter 2016 financial results on Friday, July 29, 2016 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).

NORTH CHICAGO, Ill. , June 16, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.57 per share.  The cash dividend is payable Aug. 15, 2016 to stockholders of record at the close of business on July 15, 2016 .

- AbbVie is dedicated to delivering innovative new therapies that significantly advance the standard of care - AbbVie's late- and early-stage pipelines will drive long-term sustainable performance - AbbVie's late-stage pipeline has the potential to deliver more than 20 new medicines or indications

NORTH CHICAGO, Ill. , May 31, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 37 th Annual Global Healthcare Conference on Thursday, June 9, 2016 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at

NORTH CHICAGO, Ill. , May 12, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at 1:00 p.m. Central time .